This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Elstrodt, F. Articles by Schutte, M. Search for Related Content PubMed PubMed Citation Articles by Elstrodt, F. Articles by Schutte, M.

BRCA1 Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants

Departments of ¹ Medical Oncology and ² Clinical Genetics, Josephine Nefkens Institute, Erasmus University Medical Center, Rotterdam, the Netherlands; ³ Department of Internal Medicine, University of Michigan Cancer Center, Ann Arbor, Michigan; and ⁴ Barbara Ann Karmanos Cancer Institute, Detroit, Michigan

Requests for reprints: Mieke Schutte, Department of Medical Oncology, Josephine Nefkens Institute Be414, Erasmus MC, PO Box 1738, 3000 DR Rotterdam, the Netherlands. Phone: 31-10-4638039; Fax: 31-10-4088377; E-mail: a.schutte{at}erasmusmc.nl.

Germ line mutations of the BRCA1 gene confer a high risk of breast cancer and ovarian cancer to female mutation carriers. The BRCA1 protein is involved in the regulation of DNA repair. How specific tumor-associated mutations affect the molecular function of BRCA1, however, awaits further elucidation. Cell lines that harbor BRCA1 gene mutations are invaluable tools for such functional studies. Up to now, the HCC1937 cell line was the only human breast cancer cell line with an identified BRCA1 mutation. In this study, we identified three other BRCA1 mutants from among 41 human breast cancer cell lines by sequencing of the complete coding sequence of BRCA1. Cell line MDA-MB-436 had the 5396 + 1G>A mutation in the splice donor site of exon 20. Cell line SUM149PT carried the 2288delT mutation and SUM1315MO2 carried the 185delAG mutation. All three mutations were accompanied by loss of the other BRCA1 allele. The 185delAG and 5396 + 1G>A mutations are both classified as pathogenic mutations. In contrast with wild-type cell lines, none of the BRCA1 mutants expressed nuclear BRCA1 proteins as detected with Ab-1 and Ab-2 anti-BRCA1 monoclonal antibodies. These three new human BRCA1 mutant cell lines thus seem to be representative breast cancer models that could aid in further unraveling of the function of BRCA1. (Cancer Res 2006; 66(1): 41-5)

This article has been cited by other articles:

				T. Ueki, J.-H. Park, T. Nishidate, K. Kijima, K. Hirata, Y. Nakamura, and T. Katagiri Ubiquitination and Downregulation of BRCA1 by Ubiquitin-Conjugating Enzyme E2T Overexpression in Human Breast Cancer Cells Cancer Res., November 15, 2009; 69(22): 8752 - 8760. [Abstract] [Full Text] [PDF]

				E. Alli, V. B. Sharma, P. Sunderesakumar, and J. M. Ford Defective Repair of Oxidative DNA Damage in Triple-Negative Breast Cancer Confers Sensitivity to Inhibition of Poly(ADP-Ribose) Polymerase Cancer Res., April 15, 2009; 69(8): 3589 - 3596. [Abstract] [Full Text] [PDF]

				A. M. Sieuwerts, J. Kraan, J. Bolt, P. van der Spoel, F. Elstrodt, M. Schutte, J. W. M. Martens, J.-W. Gratama, S. Sleijfer, and J. A. Foekens Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells J Natl Cancer Inst, January 7, 2009; 101(1): 61 - 66. [Abstract] [Full Text] [PDF]

				M. Zajac, M. V. Moneo, A. Carnero, J. Benitez, and B. Martinez-Delgado Mitotic catastrophe cell death induced by heat shock protein 90 inhibitor in BRCA1-deficient breast cancer cell lines Mol. Cancer Ther., August 1, 2008; 7(8): 2358 - 2366. [Abstract] [Full Text] [PDF]

				A. Hollestelle, F. Elstrodt, J. H.A. Nagel, W. W. Kallemeijn, and M. Schutte Phosphatidylinositol-3-OH Kinase or RAS Pathway Mutations in Human Breast Cancer Cell Lines Mol. Cancer Res., February 1, 2007; 5(2): 195 - 201. [Abstract] [Full Text] [PDF]

				X. Chen, C. A. Arciero, C. Wang, D. Broccoli, and A. K. Godwin BRCC36 Is Essential for Ionizing Radiation-Induced BRCA1 Phosphorylation and Nuclear Foci Formation. Cancer Res., May 15, 2006; 66(10): 5039 - 5046. [Abstract] [Full Text] [PDF]